Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide for Bone Union in Unstable Intertrochanteric Fracture
NCT03133195Phase 3Completed
- Start
- May 2017
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in intertrochanteric fracture comparing Teriparatide with Placebo (2 arms). Primary endpoint: Time to healing assessed by radiographic evidence at 24 months. Started May 2017; status: completed.
02
Drugs
teriparatide
03
Conditions
intertrochanteric fracture
Beyond the preview
Go deeper on NCT03133195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03133195.